Refractory or Relapsed Classical Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Refractory or Relapsed Classical Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| PD-1 Inhibitor or PD-1 Inhibitor Plus GVD for Relapsed/Refractory CHL (NCT04624984) | Sun Yat-sen University | 2021-04-01 |
Track Refractory or Relapsed Classical Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.